ADENOCARCINOMA OF APPENDIX

ADENOCARCINOMA OF APPENDIX was reported 67 times

These drug classes are most commonly taken by patients reporting ADENOCARCINOMA OF APPENDIX:

# Drug Count
0 Tumor Necrosis Factor Blocker [EPC] 21
1 Platinum-based Drug [EPC] 14
2 Loop Diuretic [EPC] 11
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 9
4 Nonsteroidal Anti-inflammatory Drug [EPC] 8
5 Xanthine Oxidase Inhibitor [EPC] 8
6 Aminosalicylate [EPC] 7
7 Anti-epileptic Agent [EPC] 7
8 Mood Stabilizer [EPC] 7
9 Corticosteroid [EPC] 6
10 Microtubule Inhibitor [EPC] 6
11 Folate Analog Metabolic Inhibitor [EPC] 5
12 Integrin Receptor Antagonist [EPC] 5
13 Interleukin-23 Antagonist [EPC] 4
14 Aluminum Complex [EPC] 3
15 Epidermal Growth Factor Receptor Antagonist [EPC] 3
16 Interleukin-12 Antagonist [EPC] 3
17 Proton Pump Inhibitor [EPC] 3
18 Purine Antimetabolite [EPC] 3
19 Serotonin Reuptake Inhibitor [EPC] 3
20 gamma-Aminobutyric Acid-ergic Agonist [EPC] 3
21 CD20-directed Cytolytic Antibody [EPC] 2
22 Nucleoside Metabolic Inhibitor [EPC] 2
23 Vitamin B12 [EPC] 2
24 Vitamin C [EPC] 2
25 Vitamin D [EPC] 2
26 Alkylating Drug [EPC] 1
27 Androgen Receptor Inhibitor [EPC] 1
28 Angiotensin 2 Receptor Blocker [EPC] 1
29 Calcium Channel Blocker [EPC] 1
30 Dihydropyridine Calcium Channel Blocker [EPC] 1
31 Factor Xa Inhibitor [EPC] 1
32 GLP-1 Receptor Agonist [EPC] 1
33 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1
34 Influenza A M2 Protein Inhibitor [EPC] 1
35 Interferon beta [EPC] 1
36 Interleukin-17A Antagonist [EPC] 1
37 Interleukin-6 Receptor Antagonist [EPC] 1
38 Leukocyte Growth Factor [EPC] 1
39 Opioid Agonist [EPC] 1
40 Phosphodiesterase 4 Inhibitor [EPC] 1
41 Platelet Aggregation Inhibitor [EPC] 1
42 Proteasome Inhibitor [EPC] 1
43 Provitamin D2 Compound [EPC] 1
44 Selective T Cell Costimulation Modulator [EPC] 1
45 Sulfonylurea [EPC] 1
46 Thiazide Diuretic [EPC] 1